Trial · NCT00373334
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R) Success | Nizatidine 2.5 mg/kg b.i.d. | 27 | participants | ||
| Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R) Success | Nizatidine 5.0 mg/kg b.i.d. | 32 | participants | ||
| Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R) Success | Conservative Measures Only | 31 | participants | ||
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Nizatidine 2.5 mg/kg b.i.d. | Better | 32 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Nizatidine 5.0 mg/kg b.i.d. | Better | 36 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Conservative Measures Only | Better | 29 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Nizatidine 2.5 mg/kg b.i.d. | No Change | 4 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Nizatidine 5.0 mg/kg b.i.d. | No Change | 2 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Conservative Measures Only | No Change | 6 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Nizatidine 2.5 mg/kg b.i.d. | Worse | 5 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Nizatidine 5.0 mg/kg b.i.d. | Worse | 6 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Relief | Conservative Measures Only | Worse | 4 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Nizatidine 2.5 mg/kg b.i.d. | None | 3 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Nizatidine 5.0 mg/kg b.i.d. | None | 7 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Conservative Measures Only | None | 5 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Nizatidine 2.5 mg/kg b.i.d. | Mild | 25 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Nizatidine 5.0 mg/kg b.i.d. | Mild | 26 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Conservative Measures Only | Mild | 25 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Nizatidine 2.5 mg/kg b.i.d. | Moderate | 10 | participants | |
| Investigator Assessment of Gastroesophageal Reflux Disease (GERD) Severity | Nizatidine 5.0 mg/kg b.i.d. | Moderate | 9 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00373334/results